Monday, August 24, 2009

MDV3100 Show promise

MDV3100 is a second generation androgen receptor (AR) antagonist. It seems to help with CR patients I wonder what it could do for those who have stage III? Here is the site of the manufacturer Medivation http://www.medivation.com/. Here is an article from Howard Hughes Medical Institute http://www.hhmi.org/. http://tiny.cc/HHMIMDV3100 .

No comments:

Post a Comment